Klinische Pathophysiologie
W Siegenthaler(University Hospital of Zurich), Nasser Semmo, Stefan H. E. Kaufmann(Humboldt-Universität zu Berlin), Andreas Link(Universitätsklinikum des Saarlandes), W. H. Oertel, H Schwacha, Michael Böhm(Saarland University), F. Beuschlein, K.-A. Kreuzer, B. Scheller, Peter Nawroth, Reinhard Hohlfeld(Munich Cluster for Systems Neurology), Steffen Gay(Centre Hospitalier Universitaire de Tours), Roland Gärtner, C. Arnold, Karsten Schepelmann, Jürgen Kohlhase, U. Panzer, M. Kindermann, Michael Ludwig(University of Chicago), Eberhard Passarge, D. Moradpour, W. Scherbaum, Christoph Maack(Universitätsklinikum Würzburg), Robert Bals(Ludwig-Maximilians-Universität München), Felix Rosenow, Ulrich Laufs(University Hospital Leipzig), Ulrike Hoffmann(Harvard University), Michael Geißler(Klinikum Esslingen), M. Hallek, Werner J. Pichler(ADR-AC (Switzerland)), M. Reincke, OG Opitz, Jochen Schopohl, Michael Fromm(Charité - Universitätsmedizin Berlin), R. Düsing, Ulrich Büttner, Anna Schneider, Fikret Er, T. Schaberg, Ulf Müller‐Ladner(Justus-Liebig-Universität Gießen), H. H. Peter, Beatrice Amann‐Vesti, Lothar Kanz(University of Freiburg), S. Martin, Hubert E. Blum, Werner Richter, Sigrid Harendza(Universität Hamburg), Ch. Neumann-Haefelin, D Häussinger
Cited by 93
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k